Brown, Derek, MD
Derek Brown currently has a Doctorate of Osteopathic Medicine degree. He is currently in his 4th year of psychiatry residency training, due to graduate June 2016.
Tag: 2016
Advances in Schizophrenia & Glutamate Theory
Speaker(s)
This presentation will provide a summary of research regarding the Glutamate theory of schizophrenia. It will also provide current research regarding the direction of treatment research.
Objectives:
- Discuss the development of the glutamate theory of schizophrenia
- Discuss recent research regarding the glutamate theory of schizophrenia
- Discuss therapies that target the glutamate system.
This presentation will provide an introduction to innovative treatment for schizophrenia using cognitive skills and therapy.
Objectives:
- Provide introduction to CET
- Provide background, need for and success of CET
- Increase awareness to the CET that is being utilized at Truman CBM
Barnhart – Slides in PDF format
Brown Derek glutamatehypo4 – Slides in PDF format
Kerby, Scott, MA
Scott Kerby, MA, LPC has seven years’ experience working as a substance abuse and mental health counselor and supervisor, following twelve years of previous experience as a Student Minister working with at-risk youth and their families. Kerby is a member of the Motivational Interviewing Network of Trainers (MINT) and provides training, coaching, and supervision in a wide variety of settings. He is passionate about equipping professionals with evidence-based practices that will allow them to be more effective in helping others change. Kerby is married with two sons and does his best to not embarrass his wife while coaching little league.
Building a Culture of Motivational Interviewing
Speaker(s)
This workshop focuses on developing a workplace culture that aims to build Motivational Interviewing (MI) into the DNA of the organization. Too often, time and resources are wasted in training staff in MI in ways that produce very little lasting change in practice. This workshop aims to give a clear definition of MI as a measurable skill, provide strategies that are being successfully utilized by organizations to develop and maintain MI proficiency with their staff, and introduce participants to the wide variety of resources available to aid in the development of a lasting culture of MI.
Objectives:
- Review a variety of therapeutic approaches to meet the behavioral health needs of their clients and their families
- Provide a brief overview of Motivational Interviewing as an Evidence Based Practice
- Review strategies used successfully by organizations that have developed a sustainable culture of Motivational Interviewing
- Educate on the numerous free and cost effective resources available to support ongoing MI
Recent Advances in Psychiatry
Speaker(s)
Treatment resistant hallucination leads to poor quality of life and increases in economic burden. TMS has been brain Stimulation technique has shown promising results. The presentation goals are to familiarize the psychiatrists and mental health Professional about history of TMS, Technique and review TMS application studies for Treatment Resistant Hallucination.
The presentation will outline the current utility of the standard EEG in everyday management of psychiatric conditions. The presentation will also briefly cover the areas where future expansion of the role of EEG in managing psychopharmacology are likely to occur in the near future.
Timothy Dellenbaugh, MD
Will discuss genetic influences on psychiatric drug metabolism with specific discussion of Cytochrome P450 2D6. Will review genetic causes and clinical implications of 2D6 phenotypes: ultra-rapid, extensive, intermediate, and poor. Will recommend strategies for learning cytochrome-based drug interactions.
Dellenbaugh, Timothy, MD
Dr. Dellenbaugh is Associate Chair for Education and Residency Training Director for UMKC- School of Medicine, Department of Psychiatry. He serves on committees for the School of Medicine related to Medical Student Education and Graduate Medical Education. He chaired a DHM Committee on Psychiatric Pharmacogenomics which made recommendations to Medical Directors on utilization of Pharmacogenomic Testing. He Completed Medical School at the University of Illinois and Residency Training at Kansas University- School of Medicine.
Boutros, Nash, MD
Dr. Boutros is Professor and Chair of the Department of Psychiatry at the University of Missouri in Kansas City. He is board certified in Psychiatry, Neurology and Clinical Neurophysiology with two advanced fellowship training programs at the University of Illinoi, Chicago for EEG training and University of Texas in Dallas for epileptology and behavioral neurology training. Dr. Boutros has published upward of 200 peer-reviewed papers in fields related to his topic of presentation.
Patel, Mahesh, MD
Baroda Medical college : MBBS 1975
Department Of Psychiatry, UMKC School of Medicine , Residency in Psychiatry 1989 to 1993 ;
Board Certified by ABPN
Inpatient Staff Psychiatrist at CBM for 25 bed unit,
Assistant Professor of Psychiatry ,UMKC School of Medicine ,Associate Program Director for Department of Psychiatry ,UMKC School of Medicine,
Certified by Brain Simulation laboratory ,Intensive course.,Medical University of South Carolina :Course included patient Selection, TMS technique, TMS treatment Management ,Management of Complications and Medico legal issues Oct 2015
MO Department of Health and Senior Services – Genetics and Healthy Childhood
We provide educational materials that the Missourians can be healthy preconception, during pregnancy, and that we have healthy babies and children in Missouri.
website: https://health.mo.gov/
Cognitive Behavioral Therapies for the Treatment of Schizophrenia Symptoms
Speaker(s)
This presentation will focus on reviewing and discussing a variety of evidenced-based cognitive behavioral therapies for the treatment of schizophrenia symptoms. Evidence for the efficacy of these interventions will be reviewed, and a brief demonstration of some of the interventions will be provided. Specific consideration will be given to Attention Shaping (Silverstein et. al, 2014), which has been shown to improve attention for individuals with Schizophrenia. A cognitive intervention entitled Michael’s Game (Khazaal et al., 2006) used to treat delusions will also be discussed. A pilot intervention of Michael’s Game to assist clients who are admitted to Fulton State Hospital for competency restoration who are also experiencing significant delusions will be reviewed. Lastly, a discussion concerning the implementation and application of the described interventions in a variety of settings will also be included.
Objectives:
- The use of empirical research to examine cognitive behavioral interventions used to treat symptoms of Schizophrenia.
- How to implement some of the discussed interventions through demonstrations.
- How to apply these interventions in a variety of settings, such as outpatient, inpatient, and forensic settings.